Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phytoestrogens and prostate cancer.

Colm Morrissey1, R William G Watson

  • 1Department of Surgery, Mater Misericordiae University Hospital, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland. cmorriss@nd.edu

Current Drug Targets
|March 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotoxic antibody-drug conjugates combined with BCL-XL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancer.

The Journal of clinical investigation·2026
Same author

Systematic analysis of hippo pathway signaling identifies TEAD1 as a transcriptional regulator of neuroendocrine prostate cancer.

Neoplasia (New York, N.Y.)·2026
Same author

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

Molecular cancer research : MCR·2026
Same author

Characterization and Evaluation of CD24 and NPY as Biomarkers for Metastatic Castration-Resistant Prostate Cancer.

Diagnostics (Basel, Switzerland)·2026
Same author

Molecular Characterization of KLK2 RNA Expression in Prostate Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Deep learning-based non-invasive profiling of tumor transcriptomes from cell-free DNA for precision oncology.

bioRxiv : the preprint server for biology·2026

Phytoestrogens show potential in prostate cancer management by inhibiting cancer cell growth and offering anti-androgenic effects. These plant-derived compounds may serve as alternative therapies for prostate cancer prevention and treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Phytochemistry

Background:

  • Androgens are crucial for prostate integrity and cell survival.
  • Anti-androgen therapies are primary treatments for prostate cancer but face resistance.
  • Estrogens influence prostate development and cancer, prompting research into alternatives like phytoestrogens due to estrogen therapy side effects.

Purpose of the Study:

  • To review the relationship between phytoestrogens and prostate cancer.
  • To explore the potential use of phytoestrogens in prostate cancer prevention and management.

Main Methods:

  • Review of existing literature on phytoestrogens and prostate cancer.
  • Analysis of in vitro and in vivo studies on phytoestrogen effects on prostate cancer cells.
  • Examination of proposed mechanisms of action for phytoestrogens.

Related Experiment Videos

Main Results:

  • Phytoestrogens can induce growth arrest and apoptosis in prostate cancer cells.
  • Phytoestrogens exhibit anti-androgenic effects and antioxidant activities.
  • Potential mechanisms include inhibition of key enzymes like 5alpha-reductase and aromatase.

Conclusions:

  • Phytoestrogens represent a promising alternative therapy for prostate cancer.
  • Their chemopreventative and chemotherapeutic potential warrants further investigation.